ASP Isotopes’ collaboration with TerraPower focuses on constructing a new uranium enrichment facility in South Africa. ・The ...

Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets Renergen Expected to Benefit from $750 million of Committed Deb ...

Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium MarketsRenergen ...

Silex Systems' failure to receive large amounts of funding from the most recent DOE awards disappointed investors. Read why ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation ...

To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.

A theoretical study reveals how functionalized crown ethers selectively capture light gadolinium isotopes, offering a cleaner, more efficient path for nuclear and planetary science applications.

Scientists have uncovered evidence that a newly identified niobium-rich deposit in central Australia formed during the early ...

Radionuclide drug conjugates (RDCs) have emerged as transformative agents that integrate diagnosis and therapy into a single clinical workflow.

ASP Isotopes will move ahead with implementing its proposed takeover of Renergen now that a certificate from the Takeover Regulation Panel has rendered the deal as unconditional. Implementation of the ...